Cargando…
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
Comorbidity between borderline personality disorder (BPD) and other mental disorders is common. Although no specific pharmacological treatments have been approved for the treatment of BPD, many drugs, including antidepressants such as selective serotonin reuptake inhibitors (SSRIs), mood stabilizers...
Autores principales: | Pascual, Juan C., Arias, Laia, Soler, Joaquim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276775/ https://www.ncbi.nlm.nih.gov/pubmed/37256484 http://dx.doi.org/10.1007/s40263-023-01015-6 |
Ejemplares similares
-
Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and Adolescents
por: Kennedy, Mary Jayne, et al.
Publicado: (2013) -
Comorbidity borderline-narcissistic personality disorder
por: Douk, K., et al.
Publicado: (2023) -
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review
por: Thatiparthi, Akshitha, et al.
Publicado: (2021) -
Exploring the relation between childhood trauma, temperamental traits and mindfulness in borderline personality disorder
por: Elices, Matilde, et al.
Publicado: (2015) -
“Skills for pills”: The dialectical‐behavioural therapy skills training reduces polypharmacy in borderline personality disorder
por: Soler, Joaquim, et al.
Publicado: (2022)